Scientists at the Scripps Research Institute (TSRI), the University of California (UC), Irvine and The University of Utah report that mice crippled by an autoimmune disease similar to multiple sclerosis (MS) regained the ability to walk and run after a team of researchers implanted human stem cells…
MS lesions
New research work from GlaxoSmithKline presented by Daren Ausin, PhD, at the American Academy of Neurology’s 66th Annual Meeting has implications for individuals with relapsinig-remitting multiple sclerosis. The presentation detailed a study that used GlaxoSmithKline’s ofatumumab in 231 patients with relapse-remitting multiple sclerosis. Ofatumumab is an anti-B-cell antibody, and it…
Recommended Posts
- Starting a home bakery looks different with multiple sclerosis
- Lifestyle factors may reduce or fuel inflammation in early MS, study says
- Pain, sleep, stress linked to fatigue severity in relapsing-remitting MS
- Study links MS to greater long-term memory loss over time
- With multiple sclerosis, you don’t get to choose the ladder you climb